L-R4W2 Catalog No.:M21426-C A major challenge of the

A major challenge of the current hESC/iPSC differentiation paradigm is the inability to effectively capture and long-term

InChi: InChI=1S/C47H56ClFN8O8/c1-54-42(59)16-15-37(46(54)61)57-45(60)32-11-9-12-38(43(32)47(57)62)64-25-8-6-4-3-5-7-18-50-41(58)17-20-56-23-21-55(22-24-56)19-10-26-65-40-28-33-36(29-39(40)63-2)51-30-52-44(33)53-31-13-14-35(49)34(48)27-31/h9

Smiles: CNC1=NC(=CC(NCC2=CC=C(C=C2Cl)NS(C)(=O)=O)=N1)C1=CC=CC=N1

but not ER-negative (MDA-MB-231) breast cancer cells

L-R4W2 Catalog No.:M21426-C A major challenge of theL R4W2 is a potent antagonist of vanilloid receptor 1 (VR1, TRPV1), with an IC50 of 0. 1 M. L R4W2 may act as a potent analgesic. Product information CAS Number: 206350 79 0 Molecular Weight: 1014. 19 Formula: C46H71N21O6 Chemical Name: (Z,2S) 2 [(Z) [(2S) 2 [(Z) [(2S) 2 [(Z) [(2S) 2 amino 5 carbamimidamido 1 hydroxypentylidene]amino] 5 carbamimidamido 1 hydroxypentylidene]amino] 5 carbamimidamido 1 hydroxypentylidene]amino] 5 carbamimidamido N [(1S)